Struggling with Psoriasis Treatment: What’s Holding Me Back?
Table of Contents
Estimated reading time: 8 minutes
Psoriasis, a chronic autoimmune condition, presents complex challenges for treatment due to its multifactorial nature. The immune system’s mistaken attack on healthy skin cells causes rapid cell turnover, resulting in the thick, scaly patches characteristic of psoriasis (Griffiths & Barker, 2007). Although conventional treatments offer relief, many individuals find themselves struggling to manage the disease in the long term. This article explores the difficulties faced in traditional treatments and highlights the promise of an Ayurvedic approach to psoriasis management, which focuses on long-term balance and holistic healing.
Struggling with Psoriasis Treatment
Challenges in Traditional Psoriasis Treatment
Managing psoriasis with conventional or allopathic treatments can be frustratingly unpredictable. Patients often experience varied responses to medications, and finding the right treatment regimen can feel like a moving target. Some common challenges in traditional treatments include:
- Drug Tolerance: Over time, patients may develop tolerance to treatments like corticosteroids, a phenomenon called tachyphylaxis (Lebo et al., 2011). As a result, medications lose their efficacy, requiring constant adjustments or stronger alternatives.
- Systemic Toxicity: Long-term use of systemic treatments—such as methotrexate, cyclosporine, or prolonged phototherapy—can result in toxic buildup in vital organs. For example, extended phototherapy use has been linked to an increased risk of skin cancer, making it a double-edged sword (Elmets et al., 2019).
- Formation of Anti-Drug Antibodies (ADAs): Many biologic treatments used to manage psoriasis can lead to the formation of ADAs. These antibodies neutralize the effectiveness of biologics, causing a relapse of symptoms and complicating treatment (Reich, 2014).
- Biologic Exhaustion: The effectiveness of biologic treatments may diminish over time. This phenomenon, known as biologic exhaustion, is not fully understood but poses a significant hurdle for patients relying on these drugs for long-term control (Gordon et al., 2016).
- Side Effects of Biologics: While biologics have revolutionized psoriasis treatment, their immunosuppressive nature increases the risk of infections. The need to balance these risks with treatment benefits is a constant concern for both patients and healthcare providers (Menter et al., 2008).
- Infection Risk: Psoriatic plaques can sometimes become infected, either due to bacteria or fungal agents. These infections can stall treatment progress or necessitate a change in medication, complicating management (Takeshita et al., 2017).
- Misdiagnosis: Psoriasis shares similarities with other skin conditions like eczema and seborrheic dermatitis. This overlap can lead to misdiagnosis, delaying effective treatment and allowing the condition to worsen (Parisi et al., 2013).
- Compliance Issues: Psoriasis treatments often require strict adherence, and missed doses or incorrect application can lead to flare-ups or diminished therapeutic effectiveness (Liu et al., 2017).
- Financial Constraints: The cost of biologic treatments can be prohibitive, making it difficult for many patients to afford long-term treatment. Insurance limitations further exacerbate this issue, causing treatment disruptions (Tortajada-Girbés et al., 2019).
- Stress-Induced Flare-Ups: Psoriasis is highly responsive to emotional and physical stress. Stress can trigger or worsen flare-ups, creating a vicious cycle that further complicates disease management (Dhabhar, 2014).
- Need for Combination Therapy: Many psoriasis patients require a combination of treatments—such as topical creams, systemic medications, and biologics. Managing these combinations without causing adverse drug interactions is a challenge, and finding the right balance is key to success (Menter et al., 2008).
Ayurvedic Approaches to Psoriasis Treatment
In contrast to the often symptom-focused approach of conventional medicine, Ayurveda provides a holistic strategy for treating psoriasis. According to Ayurveda, psoriasis is caused by an imbalance in the Pitta and Kapha doshas, leading to inflammation, skin irritation, and the accumulation of toxins, or Ama (Lad, 2002). Ayurvedic treatments aim to restore harmony in the body by addressing the root cause of the imbalance rather than simply alleviating symptoms.
- Addressing the Root Cause: Ayurvedic practitioners focus on identifying the unique Prakriti (constitution) and Vikruti (imbalance) of each individual. Psoriasis is seen as a disruption in the body’s digestive fire (Agni) and an accumulation of toxins. The treatment plan revolves around pacifying the aggravated Pitta and Kapha doshas while supporting digestive health and eliminating toxins (Sharma et al., 2020).
- Modulating the Immune Response: Ayurveda works to calm the immune system through the use of personalized treatments that balance the doshas. This not only reduces inflammation but also helps prevent the immune system from attacking healthy skin cells, which is at the heart of psoriasis flare-ups. By focusing on immune regulation rather than suppression, Ayurveda seeks long-term harmony (Patwardhan et al., 2015).
- Dietary Modifications: Ayurveda places great emphasis on diet. A Pitta-pacifying diet, which includes cooling, soothing foods while avoiding spicy, acidic, and fried foods, is recommended for psoriasis patients (Pole, 2006). This dietary approach supports the body’s ability to reduce internal inflammation and promotes digestive health, which is believed to play a critical role in preventing psoriasis flare-ups (Lad, 2002).
- Long-Term Prevention: Instead of quick-fix treatments, Ayurveda focuses on sustainable long-term health through lifestyle adjustments. Stress reduction through meditation, yoga, and breathing exercises is central to managing emotional triggers that can lead to psoriasis flare-ups (Dhabhar, 2014). Routine, regular sleep patterns, and a diet aligned with seasonal changes are other key elements that support the body’s natural healing process (Patwardhan et al., 2015).
Conclusion
Managing psoriasis requires a nuanced approach that addresses the complexity of the condition from both a symptomatic and root-cause perspective. While conventional treatments offer crucial symptom relief, they often come with limitations such as drug tolerance, side effects, and high costs. On the other hand, Ayurveda provides a holistic alternative that focuses on long-term balance, immune modulation, and lifestyle alignment.
For patients struggling with psoriasis, exploring Ayurvedic principles may offer additional hope in finding sustainable relief, not just by treating the skin but by addressing the broader systemic imbalances that contribute to the condition. Through this integrative lens, patients can work toward a more comprehensive and enduring approach to their health.
Medically reviewed by Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda Clinics, with over 15 years of experience in treating neurological, skin, and autoimmune diseases.
Contact Us
At EliteAyurveda Specialist Clinic, we have a panel of specialists in various medical domains, including endocrine, autoimmune & dermatology. We are renowned for our multifaceted and root-cause approach to treating chronic and difficult-to-treat disorders.
Visit our website to learn more about individualized treatment plans based on Ayurvedic principles. Connect with us to get patient testimonials and speak directly with our patients about their experiences with our treatments.
Note: This article is for informational purposes only and is not a substitute for professional medical advice.
References
1. Global Burden of Disease Study 2010 (GBD 2010) Results by Cause 1990–2010. [(accessed on 10 October 2022)]. Available online: https://ghdx.healthdata.org/record/ihme-data/gbd-2010-results-cause-1990-2010
2. Reich K., Krüger K., Mössner R., Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: A prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br. J. Dermatol. 2009;160:1040–1047. doi: 10.1111/j.1365-2133.2008.09023.x. [PubMed] [CrossRef] [Google Scholar]
3. Harden J.L., Krueger J.G., Bowcock A.M. The immunogenetics of psoriasis: A comprehensive review. J. Autoimmun. 2015;64:66–73. doi: 10.1016/j.jaut.2015.07.008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Niculet E., Radaschin D.S., Nastase F., Draganescu M., Baroiu L., Miulescu M., Arbune M., Tatu A.L. Influence of phytochemicals in induced psoriasis. Exp. Ther. Med. 2020;20:3421–3424. doi: 10.3892/etm.2020.9013. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Kamiya K., Kishimoto M., Sugai J., Komine M., Ohtsuki M. Risk factors for the development of psoriasis. Int. J. Mol. Sci. 2019;20:4347. doi: 10.3390/ijms20184347. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Kim G.K., Del Rosso J.Q. Drug-provoked psoriasis: Is it drug induced or drug aggravated?: Understanding pathophysiology and clinical relevance. J. Clin. Aesthetic Dermatol. 2010;3:32–38. [PMC free article] [PubMed] [Google Scholar]
7. International Federation of Psoriasis Associations World Psoriasis Day. 2015. [(accessed on 19 September 2022)]. Available online: https://ifpa-pso.com/our-actions/worldpsoriasis-day
8. Parisi R., Iskandar I.Y.K., Kontopantelis E., Augustin M., Griffiths C.E.M., Ashcroft D.M., Global Psoriasis Atlas National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 2020;369:1590. doi: 10.1136/bmj.m1590. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
9. Parisi R., Symmons D.P., Griffiths C.E.M., Ashcroft D.M. Identification and management of psoriasis and associated comorbidity (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J. Investig. Dermatol. 2013;133:377–385. doi: 10.1038/jid.2012.339. [PubMed] [CrossRef] [Google Scholar]
10. AlQassimi S., AlBrashdi S., Galadari H., Hashim M.J. Global burden of psoriasis—Comparison of regional and global epidemiology, 1990 to 2017. Int. J. Dermatol. 2020;59:566–571. doi: 10.1111/ijd.14864. [PubMed] [CrossRef] [Google Scholar]
11. Enamandram M., Kimball A.B. Psoriasis epidemiology: The interplay of genes and the environment. J. Investig. Dermatol. 2013;133:287–289. doi: 10.1038/jid.2012.434. [PubMed] [CrossRef] [Google Scholar]
12. Nicolescu A.C., Bucur Ș., Giurcăneanu C., Gheucă-Solovăstru L., Constantin T., Furtunescu F., Ancuța I., Constantin M.M. Prevalence and characteristics of psoriasis in Romania—First study in overall population. J. Pers. Med. 2021;11:523. doi: 10.3390/jpm11060523. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Boca A.N., Ilies R.F., Vesa S., Pop R., Tataru A.D., Buzoianu A.D. The first nation-wide study revealing epidemiologic data and life quality aspects of psoriasis in Romania. Exp. Ther. Med. 2019;18:900–904. doi: 10.3892/etm.2019.7652. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
14. Krueger G.G., Feldman S.R., Camisa C., Duvic M., Elder J.T., Gottlieb A.B., Koo J., Krueger J.G., Lebwohl M., Lowe N., et al. Two considerations for patients with psoriasis and their clinicians. J. Am. Acad. Dermatol. 2000;43:281–285. doi: 10.1067/mjd.2000.106374. [PubMed] [CrossRef] [Google Scholar]
15. Pariser D.M., Bagel J., Gelfand J.M., Korman N.J., Ritchlin C.T., Strober B.E., Van Voorhees A.S., Young M., Rittenberg S., Lebwohl M.G., et al. National psoriasis foundation. national psoriasis foundation clinical consensus on disease severity. Arch. Dermatol. 2007;143:239–242. doi: 10.1001/archderm.143.2.239. [PubMed] [CrossRef] [Google Scholar]
16. Rider P., Carmi Y., Cohen I. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int. J. Cell Biol. 2016;2016:9259646. doi: 10.1155/2016/9259646. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Related-
Know More About Ayurveda Treatment For Psoriasis
GET IN TOUCH
